Literature DB >> 8570217

Tie1, a receptor tyrosine kinase essential for vascular endothelial cell integrity, is not critical for the development of hematopoietic cells.

H R Rodewald1, T N Sato.   

Abstract

The receptor tyrosine kinase Tie1 is expressed in both vascular endothelial cells and immature hematopoietic cells. Expression of a common signaling molecule in distinct cellular lineages may suggest common ancestry of these lineages in ontogeny and/or utilization of shared signaling pathways. Tie 1-deficient mice carrying a targeted insertional mutation in germ line show defects in endothelial cell integrity resulting in edema and hemorrhage. To analyse the potential role of this kinase in hematopoietic cells, we have now compared hematopoietic compartments in wildtype and Tiel-deficient mice. The results show: (1) Total cellularity is mildly reduced comparing Tie1-/- and wildtype fetal liver from day 15.5 of gestation. (2) In vitro colony assays and cell transfer experiments of fetal liver cells into lymphocyte-deficient recombination-activating-gene-2-/- mice reveal that Tie1-/- hematopoietic progenitor cells can generate myeloid lineages as well as T and B lymphocytes. (3) Tie1-/- fetal liver cells contain long-term (at least 4 months) bone marrow-reconstituting hematopoietic stem cells suggesting that this kinase is not critical for stem cell-engraftment nor self-renewal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8570217

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Regulation of hematopoiesis and its interaction with stem cell niches.

Authors:  Fumio Arai; Atsushi Hirao; Toshio Suda
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 2.  Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?

Authors:  J Laurén; Y Gunji; K Alitalo
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

3.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

Authors:  M J Hendrix; E A Seftor; P S Meltzer; L M Gardner; A R Hess; D A Kirschmann; G C Schatteman; R E Seftor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 5.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

6.  Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.

Authors:  Jeff H Tsai; William M F Lee
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

7.  Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis.

Authors:  Mira C Puri; Alan Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  Urothelial differentiation of human amniotic fluid stem cells by urothelium specific conditioned medium.

Authors:  Henry H Kang; Julia J Kang; Hyung-Gyoo Kang; Seyung S Chung
Journal:  Cell Biol Int       Date:  2014-01-13       Impact factor: 3.612

9.  Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models.

Authors:  Alexandra Eichten; Alexander P Adler; Blerta Cooper; Jennifer Griffith; Yi Wei; George D Yancopoulos; Hsin Chieh Lin; Gavin Thurston
Journal:  Angiogenesis       Date:  2012-12-13       Impact factor: 9.596

10.  Embryogenesis of the first circulating endothelial cells.

Authors:  Cheng Cui; Michael B Filla; Elizabeth A V Jones; Rusty Lansford; Tracey Cheuvront; Sarah Al-Roubaie; Brenda J Rongish; Charles D Little
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.